Sign Up to like & get
recommendations!
1
Published in 2017 at "Veterinary and Comparative Oncology"
DOI: 10.1111/vco.12297
Abstract: Programmed death ligand 1 (PD-L1) expression in antigen-presenting cells and tumors can inhibit T cell-mediated immunity. In this study, PD-L1 mRNA and protein expression was evaluated in canine B cell lymphoma (CLL17-71), large T-cell leukemia…
read more here.
Keywords:
programmed death;
death ligand;
canine cell;
cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Veterinary and comparative oncology"
DOI: 10.1111/vco.12430
Abstract: Canine T cell lymphoma has previously been found to be a poor prognostic indicator compared with its B cell counterpart. The cyclophosphamide, doxorubicin, vincristine, and prednisolone protocol is widely accepted as a first line treatment…
read more here.
Keywords:
protocol;
prednisolone;
canine cell;
vincristine ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Cancers"
DOI: 10.3390/cancers11101438
Abstract: Canine B-cell lymphoma (CBL) is an incurable, spontaneous lymphoid malignancy constituting an accurate animal model for testing novel therapeutic strategies in human medicine. Resources of available species-specific therapeutic monoclonal antibodies (mAbs) targeting CBL are scarce.…
read more here.
Keywords:
canine cell;
canine;
dla;
cell lymphoma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23179831
Abstract: Extracellular vesicles (EVs) are formed in physiological and pathological conditions by almost all mammalian cells. They are known as submicron “molecules” that transport and horizontally transfer their cargo from maternal cells to donor cells. Moreover,…
read more here.
Keywords:
extracellular vesicles;
cell lymphoma;
leukemia derived;
canine cell ... See more keywords